CRH plc is a Dublin-headquartered global leader in building materials, producing aggregates, cement, asphalt, ready-mixed concrete, and related building products across North America and Europe. After a steep decline from a 52-week high of $131.55 to a recent close near $91, the shares have moved below a series of levels they occupied for much of 2025 and early 2026. The $120 mark stands out because it sits well above today's price, below the broad analyst consensus, and roughly midway toward reclaiming the prior highs — making it a natural psychological and technical milestone for investors asking how far a recovery can extend.
CRH has delivered resilient financial results even as its stock price has lagged. In its most recent quarterly report, the company posted earnings per share (EPS) that beat analyst estimates, with revenue rising year over year. Management has guided toward net income of roughly $3.9–$4.1 billion and diluted EPS of about $5.60–$6.05 for fiscal 2026. The shares trade at a price-to-earnings (P/E) ratio near 16–17 times trailing earnings and carry a dividend yield of roughly 1.6%, reflecting a business that remains profitable and cash-generative despite the stock's slide.
Several factors support the case that CRH could work its way back toward $120. First, the company's M&A engine continues to reshape its portfolio; the planned acquisition of Arcosa, a maker of infrastructure and construction products, is expected to add meaningfully to earnings beginning in 2027 and underscores CRH's ability to compound growth through deals. Second, CRH is a leading beneficiary of North American infrastructure and non-residential construction spending, where demand has held up better than in residential markets. Third, the company has been an active repurchaser of its own shares while also raising its dividend, and its inclusion in major U.S. equity indexes following its move to a primary New York listing broadened its investor base.
Wall Street remains notably constructive on the name. The consensus rating is a "Strong Buy," with an average 12-month price target clustered around $138–$143. Individual targets span a wide band, from roughly $105–$122 on the lower end up to $165.60 at Jefferies, which recently raised its target while keeping a Buy rating. In other words, even the more cautious analysts' objectives sit above $120, while the consensus implies upside of more than 40% from recent levels. This gap between a falling share price and rising analyst targets is one of the clearest arguments that $120 is a reachable, if not guaranteed, destination.
From a technical analysis perspective, the path to $120 is not a straight line. The $91 area — the stock's 52-week low — represents the first critical support level that must hold. Above that, the $100 round-number mark acts as a psychological resistance level, followed by a supply zone near $105–$110, where the shares traded repeatedly in recent months. The 50-day and 200-day moving averages also sit in that vicinity, meaning any sustained advance would first need to break back above these averages and convert them from resistance into support. Only after clearing that congestion would $120 come into clear focus.
The risks are equally real. CRH is a cyclical business whose earnings are sensitive to interest rates, residential and non-residential construction activity, and government infrastructure funding. A prolonged period of elevated borrowing costs or softening construction demand could pressure volumes and pricing. Rising input costs and supply-chain disruptions also weigh on margins. Finally, the stock's own downtrend is itself an obstacle: until the shares stabilize above key support and begin making higher lows, the technical picture favors further consolidation rather than a swift recovery to $120.
For investors seeking to monitor changing conditions in real time, Tickeron's AI Daily Buy/Sell Signals offer an automated way to track CRH and thousands of other stocks and ETFs. The product uses artificial intelligence to continuously analyze technical behavior and evolving market conditions, generating Buy, Sell, or Hold signals designed to help traders spot opportunities, keep tabs on existing positions, and identify shifts in trend more efficiently. Exploring these AI-generated signals can complement a broader research process when evaluating whether CRH is building the momentum needed to approach higher price levels.
Can CRH realistically reach $120? The evidence points toward a qualified "yes" over a longer horizon, but not without conditions. The strongest supports are a Strong Buy analyst consensus with an average target well above $120, solid recent earnings, and a proven acquisition strategy that should bolster future earnings. The primary risks are the stock's entrenched downtrend, its proximity to a 52-week low, and its sensitivity to interest rates and construction demand. Investors should watch whether the $91 support level holds, whether the shares can reclaim $100 and then the $105–$110 supply zone, and how management's guidance and the Arcosa integration progress. A break and sustained move above those resistance levels would meaningfully improve the odds that a climb toward $120 becomes realistic.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CRH has been closely correlated with VMC. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRH jumps, then VMC could also see price increases.
| Ticker / NAME | Correlation To CRH | 1D Price Change % | ||
|---|---|---|---|---|
| CRH | 100% | -1.39% | ||
| VMC - CRH | 75% Closely correlated | -3.26% | ||
| MLM - CRH | 75% Closely correlated | -1.76% | ||
| TTAM - CRH | 65% Loosely correlated | -3.39% | ||
| EXP - CRH | 64% Loosely correlated | -1.92% | ||
| AMRZ - CRH | 61% Loosely correlated | -2.34% | ||
More | ||||
| Ticker / NAME | Correlation To CRH | 1D Price Change % |
|---|---|---|
| CRH | 100% | -1.39% |
| CRH (3 stocks) | 82% Closely correlated | -2.13% |
| Non Energy Minerals (151 stocks) | 8% Poorly correlated | -0.55% |